ticlopidine has been researched along with Myocarditis in 5 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using a mouse model of angiotensin II (Ang II) infusion (1,500 ng/[kg·min] for 7 days), we determined the role of platelet activation in Ang II infusion-induced cardiac inflammation and fibrosis using a P2Y12 receptor inhibitor, clopidogrel (50 mg/[kg·day])." | 7.79 | Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis. ( Cui, W; Du, J; Jia, LX; Li, TT; Liu, O; Qi, GM; Qi, YF; Yang, M; Zhang, WM, 2013) |
| "Using a mouse model of angiotensin II (Ang II) infusion (1,500 ng/[kg·min] for 7 days), we determined the role of platelet activation in Ang II infusion-induced cardiac inflammation and fibrosis using a P2Y12 receptor inhibitor, clopidogrel (50 mg/[kg·day])." | 3.79 | Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis. ( Cui, W; Du, J; Jia, LX; Li, TT; Liu, O; Qi, GM; Qi, YF; Yang, M; Zhang, WM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, LX | 1 |
| Qi, GM | 1 |
| Liu, O | 1 |
| Li, TT | 1 |
| Yang, M | 1 |
| Cui, W | 1 |
| Zhang, WM | 1 |
| Qi, YF | 1 |
| Du, J | 2 |
| Du, XJ | 1 |
| Kiriazis, H | 1 |
| Opie, LH | 1 |
| Lakshmanan, M | 1 |
5 other studies available for ticlopidine and Myocarditis
| Article | Year |
|---|---|
Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis.
Topics: Angiotensin II; Animals; Clopidogrel; Fibrosis; Hypertension; Interleukin-1beta; Male; Mice; Mice, I | 2013 |
Pro-inflammatory role of platelets in hypertension-mediated end-organ damage : Editorial to: "Inhibition of Platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis" by L.-X. Jia et al.
Topics: Animals; Clopidogrel; Fibrosis; Hypertension; Male; Myocarditis; Platelet Aggregation Inhibitors; Pu | 2013 |
Hypertension, platelets, and inflammatory responses.
Topics: Animals; Fibrosis; Hypertension; Male; Myocarditis; Platelet Aggregation Inhibitors; Purinergic P2Y | 2014 |
Answer to: "Histogram and vertical bar diagram: often misapprehended concept" by M. Lakshmanan.
Topics: Animals; Fibrosis; Hypertension; Male; Myocarditis; Platelet Aggregation Inhibitors; Purinergic P2Y | 2014 |
Histogram and vertical bar diagram: often misapprehended concept.
Topics: Animals; Fibrosis; Hypertension; Male; Myocarditis; Platelet Aggregation Inhibitors; Purinergic P2Y | 2014 |